Home/ Supplements/ Zinc/ GTA-Forte

GTA-Forte

product on market Capsule Biotics Research Corporation Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 43% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Zinc, selenium, and copper are essential minerals with strong evidence for supporting immune function and antioxidant defenses. Rubidium and porcine glandular concentrates have limited research regarding their efficacy and clinical utility in humans. Overall, the evidence coverage for this specific ingredient profile is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for GTA-Forte
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Other Combinations
Product Type
43%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

10 mg (67% DV)
Within RDA (0.9× RDA) 263 studies (A:6, B:134)
5 mcg (7% DV)
Within RDA (0.1× RDA) 173 studies (A:0, B:67)
1 mg (5% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
Rubidium
5 mcg
Porcine Glandular Concentrate
5 mg
Superoxide Dismutase
30 mcg
Catalase
30 mcg

Other Ingredients

Gelatin Water
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

RECOMMENDATION: One (1) capsule one (1) to three (3) times each day as a dietary supplement or as otherwise directed by a healthcare professional.

Warnings & Precautions

Caution: Not recommended for pregnant or lactating women.

KEEP OUT OF REACH OF CHILDREN

Sealed with an imprinted safety seal for your protection.

Additional Information

Store in a cool, dry area.

Rev. 5/09

Metadata

Product Details

DSLD Entry Date2013-05-24
Product TypeOther Combinations
FormCapsule
DSLD ID21839
Data Updated2026-04-11
Research

Research Evidence

397
Research Sources
55
Avg Quality
200
Meta Analysis
68
Rct
58
Systematic Review
53
Clinical Trial
9
Cochrane Review
2
Narrative Review
2
Regulatory Source
1
Observational
1
Other
1
Openfda Safety
A Zinc supplementation for improving pregnancy and infant outcome
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
Narrative Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Oral zinc for treating diarrhoea in children
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2021 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2010 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Compression bandages or stockings versus no compression for treating venous leg ulcers
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for mental and motor development in children
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Zinc for the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Zinc →
Compare

Similar Products

View all Zinc products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.